Cited by 561Cancer, Hypoxia, and MetabolismMetabolism, Diabetes, and CancerCancer and biochemical research

The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.

Pyruvate into lactate and back: From the Warburg effect to symbiotic energy fuel exchange in cancer cells

Feron, Olivier·2009·Radiotherapy and Oncology

DOI 10.1016/j.radonc.2009.06.025

Open this paper in CoChat — free account

Abstract

Tumor cells fuel their metabolism with glucose and glutamine to meet the bioenergetic and biosynthetic demands of proliferation. Hypoxia and oncogenic mutations drive glycolysis, with the pyruvate to lactate conversion being promoted by increased expression of lactate dehydrogenase A and inactivation of pyruvate dehydrogenase. The NAD+ pool is consecutively regenerated and supports the high glycolytic flux required to produce anabolic intermediates. Glutaminolysis provides metabolic intermediates such as alpha-ketoglutarate to feed and thereby maintain the tricarboxylic acid cycle as a biosynthetic hub. Glycolysis and glutaminolysis share the capacity to generate NADPH, from the pentose phosphate pathway and through the malate conversion into pyruvate, respectively. Both pathways ultimately lead to the secretion of lactate. More than a waste product, lactate was recently identified as a major energy fuel in tumors. Lactate produced by hypoxic tumor cells may indeed diffuse and be taken up by oxygenated tumor cells. Preferential utilization of lactate for oxidative metabolism spares glucose which may in turn reach hypoxic tumor cells. Monocarboxylate transporter 1 regulates the entry of lactate into oxidative tumor cells. Its inhibition favors the switch from lactate-fuelled respiration to glycolysis and consecutively kills hypoxic tumor cells from glucose starvation. Combination with radiotherapy renders remaining cells more sensitive to irradiation, emphasizing how interference with tumor cell metabolism may complement current anticancer modalities.

Integrity signals

Registry

Crossref · 10.1016/j.radonc.2009.06.025

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

On the origin of cancer cells
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
On Respiratory Impairment in Cancer Cells
Warburg, O. H. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,472
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., & Denko, N. C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.012 · Cited by 2,267
c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism
Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124
Ras, PI(3)K and mTOR signalling controls tumour cell growth
Shaw, R. J., & Cantley, L. C. (2006) · Nature · doi:10.1038/nature04869 · Cited by 2,019

Show all 38 references

Sorted by citations

Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Aerobic glycolysis: Meeting the metabolic requirements of cell proliferation
Lunt, S. Y., & Vander Heiden, M. G. (2011) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-154237 · Cited by 3,057
To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
Danhier, F., Féron, O., & Véronique Préat, A. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.027 · Cited by 2,891
Glucose feeds the TCA cycle via circulating lactate
Hui, S., Ghergurovich, J. M., Morscher, R. J., Jang, C., Teng, X., Lu, W., Esparza, L. A., Reya, T., Zhan, L., Yanxiang Guo, J., et al. (2017) · Nature · doi:10.1038/nature24057 · Cited by 1,721
Interfering with pH regulation in tumours as a therapeutic strategy
Neri, D., & Supuran, C. T. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3554 · Cited by 1,551
Tumor glycolysis as a target for cancer therapy: progress and prospects
Ganapathy‐Kanniappan, S., & Geschwind, J.-F. H. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-152 · Cited by 1,428
Mitochondrial metabolism and cancer
Porporato, P. E., Filigheddu, N., Pedro, J. M. B., Kroemer, G., & Galluzzi, L. (2017) · Cell Research · doi:10.1038/cr.2017.155 · Cited by 1,323
Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?
Hay, N. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.77 · Cited by 1,152
Tumour acidosis: from the passenger to the driver's seat
Corbet, C., & Féron, O. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2017.77 · Cited by 1,028
Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation (Review)
Zheng, J. (2012) · Oncology Letters · doi:10.3892/ol.2012.928 · Cited by 986
p53 and metabolism
Vousden, K. H., & Ryan, K. M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2715 · Cited by 959
Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism
Zhao, H., Yang, L., Baddour, J., Achreja, A., Bernard, V., Moss, T., Marini, J. C., Tudawe, T., Seviour, E. G., San Lucas, F. A., et al. (2016) · eLife · doi:10.7554/elife.10250 · Cited by 927
Lactate Influx through the Endothelial Cell Monocarboxylate Transporter MCT1 Supports an NF-κB/IL-8 Pathway that Drives Tumor Angiogenesis
Végran, F., Boidot, R., Michiels, C., Sonveaux, P., & Feron, O. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2828 · Cited by 816
Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come
Yingchoncharoen, P., Kalinowski, D. S., & Richardson, D. R. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.012070 · Cited by 748
Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy
Abdel-Wahab, A. F., Mahmoud, W., & Al-Harizy, R. M. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104511 · Cited by 598
Targeting the lactate transporter MCT1 in endothelial cells inhibits lactate-induced HIF-1 activation and tumor angiogenesis
Sonveaux, P., Copetti, T., De Saedeleer, C. J., Végran, F., Verrax, J., Kennedy, K. M., Moon, E. J., Dhup, S., Danhier, P., Frérart, F., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033418 · Cited by 536
Metabolic heterogeneity confers differences in melanoma metastatic potential
Tasdogan, A., Faubert, B., Ramesh, V., Ubellacker, J. M., Shen, B., Solmonson, A., Murphy, M. M., Gu, Z., Gu, W., Martin, M., et al. (2020) · Nature · doi:10.1038/s41586-019-1847-2 · Cited by 509
Lactate Contribution to the Tumor Microenvironment: Mechanisms, Effects on Immune Cells and Therapeutic Relevance
Romero‐Garcia, S., Moreno‐Altamirano, M. M. B., Prado-García, H., & Sánchez‐García, F. J. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00052 · Cited by 529
Tumor glycolysis, an essential sweet tooth of tumor cells
Paul, S., Ghosh, S., & Kumar, S. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.09.007 · Cited by 449
Multiple Biological Activities of Lactic Acid in Cancer: Influences on Tumor Growth,Angiogenesis and Metastasis
Dhup, S., Dadhich, R. K., Porporato, P. E., & Sonveaux, P. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799504902 · Cited by 429
Therapeutic Targeting of the Pyruvate Dehydrogenase Complex/Pyruvate Dehydrogenase Kinase (PDC/PDK) Axis in Cancer
Stacpoole, P. W. (2017) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djx071 · Cited by 418
Monocarboxylate transporters in the brain and in cancer
Pérez‐Escuredo, J., Hée, V. F. V., Sboarina, M., Falces, J., Payen, V. L., Pellerin, L., & Sonveaux, P. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.03.013 · Cited by 415
Cancer‐generated lactic acid: a regulatory, immunosuppressive metabolite?
Choi, S. Y. C., Collins, C. C., Gout, P. W., & Wang, Y. Z. (2013) · The Journal of Pathology · doi:10.1002/path.4218 · Cited by 339
Mitochondrial p32 Protein Is a Critical Regulator of Tumor Metabolism via Maintenance of Oxidative Phosphorylation
Fogal, V., Richardson, A. D., Karmali, P. P., Scheffler, I. E., Smith, J. W., & Ruoslahti, E. I. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01101-09 · Cited by 341
Prognostic role of lactate dehydrogenase in solid tumors: A systematic review and meta-analysis of 76 studies
Petrelli, F., Cabiddu, M., Coinu, A., Borgonovo, K., Ghilardi, M., Lonati, V., & Barni, S. (2015) · Acta Oncologica · doi:10.3109/0284186x.2015.1043026 · Cited by 324
Role of the tumor microenvironment in tumor progression and the clinical applications (Review)
YUAN, Y., JIANG, Y.-C., SUN, C.-K., & CHEN, Q.-M. (2016) · Oncology Reports · doi:10.3892/or.2016.4660 · Cited by 320
Lactate shuttles at a glance: from physiological paradigms to anti-cancer treatments
Draoui, N., & Féron, O. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.007724 · Cited by 307
Tumor Microenvironment in Head and Neck Squamous Cell Carcinoma
Curry, J., Sprandio, J. D., Cognetti, D. M., Luginbuhl, A., Bar‐Ad, V., Pribitkin, E. A., & Tuluc, M. (2014) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.03.003 · Cited by 295
Structure and Function of the Mitochondrial Ribosome
Greber, B. J., & Ban, N. (2016) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060815-014343 · Cited by 303
Warburg Meets Autophagy: Cancer-Associated Fibroblasts Accelerate Tumor Growth and Metastasis via Oxidative Stress, Mitophagy, and Aerobic Glycolysis
Pavlides, S., Vera, I., Gândara, R., Sneddon, S., Pestell, R. G., Mercier, I., Martinez‐Outschoorn, U., Whitaker‐Menezes, D., Howell, A., Sotgia, F., et al. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4243 · Cited by 299
Autophagy contributes to resistance of tumor cells to ionizing radiation
Chaachouay, H., Ohneseit, P., Toulany, M., Kehlbach, R., Multhoff, G., & Rodemann, H. P. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.06.002 · Cited by 270
The matrix environmental and cell mechanical properties regulate cell migration and contribute to the invasive phenotype of cancer cells
Mierke, C. T. (2019) · Reports on Progress in Physics · doi:10.1088/1361-6633/ab1628 · Cited by 267
Drug resistance in pancreatic cancer: Impact of altered energy metabolism
Grasso, C., Jansen, G., & Giovannetti, E. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.03.026 · Cited by 260
Advances in nanomedicine for cancer starvation therapy
Yu, S., Chen, Z., Zeng, X., Chen, X., & Gu, Z. (2019) · Theranostics · doi:10.7150/thno.38261 · Cited by 241
Endothelial cell metabolism and tumour angiogenesis: glucose and glutamine as essential fuels and lactate as the driving force
Polet, F., & Féron, O. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12016 · Cited by 232
Metabolism of activated T lymphocytes
Maciolek, J. A., Pasternak, J. A., & Wilson, H. L. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.01.006 · Cited by 232
Overview on Clinical Relevance of Intra-Tumor Heterogeneity
Stanta, G., & Bonin, S. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00085 · Cited by 227
E-Cadherin loss associated with EMT promotes radioresistance in human tumor cells
Theys, J., Jutten, B., Habets, R., Paesmans, K., Groot, A. J., Lambin, P., Wouters, B. G., Lammering, G., & Vooijs, M. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.05.044 · Cited by 221
Regulation of Monocarboxylate Transporter MCT1 Expression by p53 Mediates Inward and Outward Lactate Fluxes in Tumors
Boidot, R., Végran, F., Meulle, A., Breton, A. L., Dessy, C., Sonveaux, P., Lizard‐Nacol, S., & Féron, O. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2474 · Cited by 238
The Warburg metabolism fuels tumor metastasis
Lu, J. (2019) · Cancer and Metastasis Reviews · doi:10.1007/s10555-019-09794-5 · Cited by 221
The HK2 Dependent “Warburg Effect” and Mitochondrial Oxidative Phosphorylation in Cancer: Targets for Effective Therapy with 3-Bromopyruvate
Lis, P., Dyląg, M., Niedźwiecka, K., Ko, Y. H., Pedersen, P. L., Goffeau, A., & Ułaszewski, S. (2016) · Molecules · doi:10.3390/molecules21121730 · Cited by 205
Lactate is a mediator of metabolic cooperation between stromal carcinoma associated fibroblasts and glycolytic tumor cells in the tumor microenvironment
Rattigan, Y. I., Patel, B. B., Ackerstaff, E., Sukenick, G., Koutcher, J. A., Glod, J. W., & Banerjee, D. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.11.014 · Cited by 196
Extracellular acidity, a “reappreciated” trait of tumor environment driving malignancy: perspectives in diagnosis and therapy
Peppicelli, S., Bianchini, F., & Calorini, L. (2014) · Cancer and Metastasis Reviews · doi:10.1007/s10555-014-9506-4 · Cited by 195
Interruption of lactate uptake by inhibiting mitochondrial pyruvate transport unravels direct antitumor and radiosensitizing effects
Corbet, C., Bastien, E., Draoui, N., Doix, B., Mignion, L., Jordan, B. F., Marchand, A., Vanherck, J., Chaltin, P., Schakman, O., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03525-0 · Cited by 189
Targeting Metabolic Remodeling in Glioblastoma Multiforme
Wolf, A., Agnihotri, S., & Guha, A. (2010) · Oncotarget · doi:10.18632/oncotarget.190 · Cited by 193
Proton channels and exchangers in cancer
Spugnini, E. P., Sonveaux, P., Stock, C. M., Pérez‐Sayáns, M., Milito, A. D., Avnet, S., Garcı́a, A. G., Harguindey, S., & Fais, S. (2014) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.10.015 · Cited by 186
The pivotal roles of mitochondria in cancer: Warburg and beyond and encouraging prospects for effective therapies
Mathupala, S. P., Ko, Y. H., & Pedersen, P. L. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.03.025 · Cited by 186
Mitochondrial ribosomes in cancer
Kim, H. J., Maiti, P., & Barrientos, A. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.04.004 · Cited by 181
Monocarboxylate transporters 1 and 4 are involved in the invasion activity of human lung cancer cells
Izumi, H., Takahashi, M., Uramoto, H., Nakayama, Y., Oyama, T., Wang, K., Sasaguri, Y., Nishizawa, S., & Kohno, K. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.01908.x · Cited by 180
Mitochondrial and plasma membrane lactate transporter and lactate dehydrogenase isoform expression in breast cancer cell lines
Hussien, R., & Brooks, G. A. (2010) · Physiological Genomics · doi:10.1152/physiolgenomics.00177.2010 · Cited by 175
Cancer cell metabolism and mitochondria: Nutrient plasticity for TCA cycle fueling
Corbet, C., & Féron, O. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.01.002 · Cited by 174
Non-coding RNAs: the new central dogma of cancer biology
Saw, P. E., Xu, X., Chen, J., & Song, E. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1700-9 · Cited by 180
Peptide-functionalized liposomes as therapeutic and diagnostic tools for cancer treatment
Sonju, J. J., Dahal, A., Singh, S. S., & Jois, S. D. S. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.09.055 · Cited by 175
Blocking Lipid Synthesis Overcomes Tumor Regrowth and Metastasis after Antiangiogenic Therapy Withdrawal
Sounni, N. E., Cimino, J., Blacher, S., Primac, I., Truong, A., Mazzucchelli, G., Paye, A., Calligaris, D., Debois, D., Tullio, P. D., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.05.022 · Cited by 169
Targeting pyruvate dehydrogenase kinase signaling in the development of effective cancer therapy
Anwar, S., Shamsi, A., Mohammad, T., Islam, A., & Hassan, M. I. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188568 · Cited by 168
Understanding the central role of citrate in the metabolism of cancer cells
Icard, P., Poulain, L., & Lincet, H. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.10.007 · Cited by 167
Bioenergetic Adaptations in Chemoresistant Ovarian Cancer Cells
Dar, S. A., Chhina, J., Mert, İ., Chitale, D. A., Buekers, T., Kaur, H., Giri, S., Munkarah, A. R., & Rattan, R. (2017) · Scientific Reports · doi:10.1038/s41598-017-09206-0 · Cited by 160
Serum Lactate Dehydrogenase Predicts for Overall Survival Benefit in Patients With Metastatic Renal Cell Carcinoma Treated With Inhibition of Mammalian Target of Rapamycin
Armstrong, A. J., George, D. J., & Halabi, S. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.9631 · Cited by 156
Metabolic interplay between glycolysis and mitochondrial oxidation: The reverse Warburg effect and its therapeutic implication
Lee, M. (2015) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v6.i3.148 · Cited by 152
Utilizing hydrogen sulfide as a novel anti‐cancer agent by targeting cancer glycolysis and p H imbalance
Lee, Z., Teo, X., Tay, E. Y., Tan, C., Hagen, T., Moore, P. K., & Deng, L. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12773 · Cited by 149
Redox Paradox: A Novel Approach to Therapeutics-Resistant Cancer
Chaiswing, L., Clair, W. H. S., & Clair, D. K. S. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7485 · Cited by 149
Impact of Metabolism in on T-Cell Differentiation and Function and Cross Talk with Tumor Microenvironment
Kouidhi, S., Elgaaïed, A. B., & Chouaïb, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00270 · Cited by 145
A ketogenic diet rescues hippocampal memory defects in a mouse model of Kabuki syndrome
Benjamin, J. S., Pilarowski, G. O. W., Carosso, G. A., Zhang, L., Huso, D. L., Goff, L. A., Vernon, H. J., Hansen, K. D., & Bjornsson, H. T. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1611431114 · Cited by 135
Hallmarks of cancer: of all cancer cells, all the time?
Floor, S. L., Dumont, J. E., Maenhaut, C., & Raspé, E. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.06.005 · Cited by 135
Fenton/Fenton-like metal-based nanomaterials combine with oxidase for synergistic tumor therapy
Cao, W., Jin, M., Yang, K., Chen, B., Xiong, M., Li, X., & Cao, G. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01074-1 · Cited by 141
Peptide‐Based Multifunctional Nanomaterials for Tumor Imaging and Therapy
Zhang, C., Wu, W. H., Li, R., Qiu, W., Zhuang, Z., Cheng, S., & Zhang, X. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201804492 · Cited by 136
Metabolic Symbiosis and Immunomodulation: How Tumor Cell-Derived Lactate May Disturb Innate and Adaptive Immune Responses
Morrot, A., da Fonseca, L. M., Salustiano, E. J., Gentile, L. B., Conde, L., Filardy, A. A., Franklim, T. N., da Costa, K. M., Freire-de-Lima, C. G., & Freire‐de‐Lima, L. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00081 · Cited by 128
The Chemopreventive Effect of the Dietary Compound Kaempferol on the MCF-7 Human Breast Cancer Cell Line Is Dependent on Inhibition of Glucose Cellular Uptake
Azevedo, C., Correia‐Branco, A., Araújo, J. R., Guimarães, J. T., Keating, E., & Martel, F. (2015) · Nutrition and Cancer · doi:10.1080/01635581.2015.1002625 · Cited by 125
Antitumor Activity of 7-Aminocarboxycoumarin Derivatives, a New Class of Potent Inhibitors of Lactate Influx but Not Efflux
Draoui, N., Schicke, O., Seront, E., Bouzin, C., Sonveaux, P., Riant, O., & Féron, O. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0653 · Cited by 124
A global view of the biochemical pathways involved in the regulation of the metabolism of cancer cells
Icard, P., & Lincet, H. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.07.001 · Cited by 133
Acidic tumor microenvironment in human melanoma
Böhme, I., & Bosserhoff, A. (2016) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12495 · Cited by 126
Targeting cancer cell metabolism in pancreatic adenocarcinoma
Cohen, R., Neuzillet, C., Tijeras‐Raballand, A., Faivre, S. J., Gramont, A. D. E., & Raymond, É. (2015) · Oncotarget · doi:10.18632/oncotarget.4160 · Cited by 119
Pathophysiology of type 2 diabetes and the impact of altered metabolic interorgan crosstalk
Sanches, J. M., Zhao, L. N., Salehi, A. A., Wollheim, C. B., & Kaldis, P. (2021) · FEBS Journal · doi:10.1111/febs.16306 · Cited by 136
Downregulation of MCT1 inhibits tumor growth, metastasis and enhances chemotherapeutic efficacy in osteosarcoma through regulation of the NF-κB pathway
Zhao, Z., Wu, M.-S., Zou, C., Tang, Q., Lu, J., Liu, D., Wu, Y., Yin, J., Xie, X., Shen, J., et al. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.08.042 · Cited by 118
Metabolism and TAM functions—it takes two to tango
Mazzone, M., Menga, A., & Castegna, A. (2017) · FEBS Journal · doi:10.1111/febs.14295 · Cited by 115
Cancer heterogeneity is not compatible with one unique cancer cell metabolic map
Strickaert, A., Saiselet, M., Dom, G., Deken, X. D., Dumont, J. E., Féron, O., Sonveaux, P., & Maenhaut, C. (2016) · Oncogene · doi:10.1038/onc.2016.411 · Cited by 111
Targeting the miR-122/PKM2 autophagy axis relieves arsenic stress
Wang, Y., Zhao, H., Guo, M., Fei, D., Zhang, L., & Xing, M. (2019) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2019.121217 · Cited by 109
Lactate, a Neglected Factor for Diabetes and Cancer Interaction
Wu, Y., Dong, Y., Atefi, M. S., Liu, Y., Elshimali, Y., & Vadgama, J. V. (2016) · Mediators of Inflammation · doi:10.1155/2016/6456018 · Cited by 107
Carbon quantum dots: A promising nanocarrier for bioimaging and drug delivery in cancer
Jana, P., & Dev, A. (2022) · Materials Today Communications · doi:10.1016/j.mtcomm.2022.104068 · Cited by 106
Membrane transporters in a human genome-scale metabolic knowledgebase and their implications for disease
Sahoo, S., Aurich, M. K., Jónsson, J. J., & Thiele, I. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00091 · Cited by 105
Yeast-like chronological senescence in mammalian cells: phenomenon, mechanism and pharmacological suppression
Leontieva, O. V., & Blagosklonny, M. V. (2011) · Aging · doi:10.18632/aging.100402 · Cited by 101
Anticancer mechanism of coumarin-based derivatives
Yadav, A. K., Shrestha, R. M., & Yadav, P. N. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116179 · Cited by 110
The progression from a lower to a higher invasive stage of bladder cancer is associated with severe alterations in glucose and pyruvate metabolism
Conde, V. R., Oliveira, P. F., Nunes, A. R., Rocha, C. S. F., Ramalhosa, E., Pereira, J. A., Alves, M. G., & Silva, B. M. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.04.007 · Cited by 96
Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis
Bovenzi, C. D., Hamilton, J., Tassone, P. T., Johnson, J. M., Cognetti, D. M., Luginbuhl, A., Keane, W. M., Zhan, T., Tuluc, M., Bar‐Ad, V., et al. (2015) · BioMed Research International · doi:10.1155/2015/242437 · Cited by 98
PGC1α: Friend or Foe in Cancer?
Mastropasqua, F., Girolimetti, G., & Shoshan, M. C. (2018) · Genes · doi:10.3390/genes9010048 · Cited by 97
Fucoidan Structure and Its Impact on Glucose Metabolism: Implications for Diabetes and Cancer Therapy
Mabate, B., Daub, C. D., Malgas, S., Edkins, A. L., & Pletschke, B. I. (2021) · Marine Drugs · doi:10.3390/md19010030 · Cited by 96
The Future of Radiobiology
Kirsch, D. G., Diehn, M., Kesarwala, A. H., Maity, A. M., Morgan, M. A., Schwarz, J. K., Bristow, R. G., Demaria, S., Eke, I., Griffin, R. J., et al. (2017) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djx231 · Cited by 96
New drugs are not enough‑drug repositioning in oncology: An update
Armando, R., Mengual G�mez, D., & Gomez, D. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.4966 · Cited by 90
Surface Engineering of Nanoparticles for Targeted Delivery to Hepatocellular Carcinoma
Lu, J., Wang, J., & Ling, D. (2017) · Small · doi:10.1002/smll.201702037 · Cited by 88
Lactate and Lactylation: Dual Regulators of T-Cell-Mediated Tumor Immunity and Immunotherapy
Hao, Z.-N., Tan, X.-P., Zhang, Q., Li, J., Xia, R., & Ma, Z. (2024) · Biomolecules · doi:10.3390/biom14121646 · Cited by 96
Metformin increases PDH and suppresses HIF-1α under hypoxic conditions and induces cell death in oral squamous cell carcinoma
Guimarães, T. A., Farias, L. C., Santos, E. S., Fraga, C. A. D. C., Orsine, L. A., Teles, L. D. F., Feltenberger, J. D., de Jesus, S. F., de Souza, M. G., Santos, S. H. S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10842 · Cited by 86
Role of lactate and lactate metabolism in liver diseases (Review)
Yao, S., Chai, H., Tao, T., Zhang, L. R., Yang, X., Li, X., Yi, Z., Wang, Y., An, J., Wen, G., et al. (2024) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2024.5383 · Cited by 89
Mitochondrial dysfunction in cancer chemoresistance
Guaragnella, N., Giannattasio, S., & Moro, L. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.07.027 · Cited by 87
The Role of Mitochondrial Fat Oxidation in Cancer Cell Proliferation and Survival
Oliveira, M., & Liesa, M. (2020) · Cells · doi:10.3390/cells9122600 · Cited by 89
Metabolic tricks of cancer cells
Hönigová, K., Navrátil, J., Peltanová, B., Polanska, H. H., Raudenská, M., & Masařík, M. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188705 · Cited by 84
PI3K signaling-regulated metabolic reprogramming: From mechanism to application
Su, W. Y., Tian, L. Y., Guo, L. P., Huang, L., & Gao, W. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188952 · Cited by 87
A Metabolism Toolbox for CAR T Therapy
Xu, X., Gnanaprakasam, J. R., Sherman, J. W., & Wang, R. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00322 · Cited by 82
Evolution of Tumor Metabolism might Reflect Carcinogenesis as a Reverse Evolution process (Dismantling of Multicellularity)
Alfarouk, K. O., Shayoub, M. E. A., Muddathir, A. K., Elhassan, G. O., & Bashir, A. H. H. (2011) · Cancers · doi:10.3390/cancers3033002 · Cited by 81
TP53 induced glycolysis and apoptosis regulator (TIGAR) knockdown results in radiosensitization of glioma cells
Peña-Rico, M. Á., Calvo-Vidal, M. N., Villalonga-Planells, R., Martínez‐Soler, F., Gimenez‐Bonafé, P., Navarro‐Sabaté, À., Tortosa, A., Bartrons, R., & Manzano, À. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.07.002 · Cited by 81
Predictive and on-treatment monitoring biomarkers in advanced melanoma: Moving toward personalized medicine
Tarhini, A. A., & Kudchadkar, R. R. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2018.09.005 · Cited by 84

Authors: Feron, O.
Venue: Radiotherapy and Oncology
Publisher: Elsevier BV
Published: 2009-09
Volume: 92
Issue: 3
Pages: 329-333
ISSN: 0167-8140 (ISSN-L)
DOI: 10.1016/j.radonc.2009.06.025
OpenAlex: W2002922559
Cited by: 559
References: 38
Citations by year: 2026: 13 · 2025: 37 · 2024: 25 · 2023: 28 · 2022: 40 · 2021: 50 · 2020: 44 · 2019: 37 · 2018: 32 · 2017: 30 · 2016: 38 · 2015: 32 · 2014: 35 · 2013: 42 · 2012: 17
FWCI: 1.59
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Radiotherapy and Oncology (publishedVersion)
PubMed (publishedVersion)
Digital Access to Libraries (submittedVersion)
Funders: Fonds De La Recherche Scientifique - FNRS
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
Keywords: Warburg effect, cancer metabolism, lactate, pyruvate, glycolysis, glutaminolysis, NAD+ regeneration, NADPH, pentose phosphate pathway, MCT1, LDHA, pyruvate dehydrogenase, hypoxia, oxidative metabolism, TCA cycle, alpha-ketoglutarate, glucose deprivation, combined radiotherapy
MeSH terms: Cell Survival, Energy Metabolism, Glycolysis, Humans, NAD, NADP, Neoplasms, Oxidation-Reduction, Radiation Tolerance, Sensitivity and Specificity, Cell Hypoxia, Cell Death, Pyruvic Acid, Lactic Acid, Cell Line, Tumor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Pyruvate into lactate and back: From the Warburg effect to symbiotic energy fuel exchange in cancer cells

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks